Dr. Robert Doebele cofounded Rain Therapeutics in April 2017 and serves as the executive vice president, chief scientific officer and is the chair of the Scientific Advisory Board. Prior to joining Rain full time, Dr Doebele was an Associate Professor of Medicine in the Division of Medical Oncology at the University of Colorado School of Medicine. He also served as the Director of the Thoracic Oncology Research Initiative at the University of Colorado Cancer Center; and was the principle investigator of the University of Colorado Lung Cancer Specialized Program of Research Excellence. He is also a Senior Editor of the AACR journal Clinical Cancer Research.
Bob received his AB in Molecular Biology from Princeton University, and received his MD, PhD in Immunology from the University of Pennsylvania. He conducted his internal medicine residency and a medical oncology fellowship at the University of Chicago.